| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/03/2004 | US6686148 Methods for targeting RNA molecules |
| 02/03/2004 | US6685972 Extracting the herb with a nonpolar solvent like ethanol, partitioning the extract between water and a hydrocarbon, followed by evaporative crystallization from the hexane phase to produce pure artemisinin. |
| 02/03/2004 | US6685971 Oil homogenized with sterols; protective coating for stomach |
| 02/03/2004 | US6685970 Compositions containing proanthocyanidin and a vitamin B6 derivative or a salt thereof |
| 02/03/2004 | US6685965 Process for stabilizing levogyre ascorbic acid (laa), a stable aqueous laa composition, a process for preparing a stable topical solution, an emulsion, a vitamin product, and a method for cosmetic, pharmaceutical or nutritional treatment |
| 02/03/2004 | US6685964 Coated crystals |
| 02/03/2004 | US6685962 Enclosed in insoluble membranes |
| 02/03/2004 | US6685960 Solid lipidic nanospheres suitable to a fast internalization into cells |
| 02/03/2004 | US6685959 Pharmaceutical compositions comprising 2-isoxazoles-8-aminotetralin derivatives |
| 02/03/2004 | US6685958 E.g., 7-(3-amino-2,3,4,5,6,7-hexahydro-1h-azepin-1-yl)-8-chloro-1-cyclopropyl-6 -fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid; treatment of ocular and periocular infections. |
| 02/03/2004 | US6685954 For application to skin |
| 02/03/2004 | US6685953 Water retention capacity; moisturizer; alkoxyalkyamides of alkylenedicarboxylic acids |
| 02/03/2004 | US6685951 Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine |
| 02/03/2004 | US6685928 Therapeutic compositions and methods |
| 02/03/2004 | US6685924 Conjugate, its preparation and use |
| 02/03/2004 | US6685917 Treatment of mucositis |
| 02/03/2004 | CA2355987C Bicyclic amide derivatives and their use as muscle relaxants |
| 02/03/2004 | CA2300806C Dexamethasone gel |
| 02/03/2004 | CA2248167C Patch containing isosorbide dinitrate |
| 02/03/2004 | CA2245661C Multiple sclerosis treatment |
| 02/03/2004 | CA2182244C Camptothecin derivatives |
| 02/03/2004 | CA2128876C Triazolopyrimidine derivatives as angiotensin ii receptor antagonists |
| 02/03/2004 | CA2100655C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 02/03/2004 | CA2092510C Crystalline forms of endo-2,3-dihydro-n-(8-methyl-8-azabicyclo-[3.2.1.]oct-3-yl)-2-oxo-1h-benzimidazole-1-carboxamide hydrochloride monohydrate and of endo-3 ethyl-2,3-dihydro-n-(8-methyl-8-azabicyclo[3.2.1.]oct-3-yl)-2-oxo-1h-benzimidazole-1-carboxamide hydrochloride monohydrate |
| 02/03/2004 | CA2067151C Aica riboside analogs |
| 02/02/2004 | CA2435561A1 Medication to prevent fibroblasts from differentiating to adipocytes |
| 01/31/2004 | CA2436469A1 Composition for heart disease, method to prepare same and uses thereof |
| 01/29/2004 | WO2004009827A2 Preparation of microbial oil containing polyunsaturated fatty acids |
| 01/29/2004 | WO2004009816A1 Methods of treating conditions associated with an edg-1 receptor |
| 01/29/2004 | WO2004009784A2 Novel inhibitors of kinases |
| 01/29/2004 | WO2004009630A1 Regulation of human serotonin receptor |
| 01/29/2004 | WO2004009627A1 Pegylated erythropoietic compounds |
| 01/29/2004 | WO2004009613A1 Anti-inflammatory or anti-allergic androstane complexes |
| 01/29/2004 | WO2004009603A1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods |
| 01/29/2004 | WO2004009602A1 Pyrazolopyrimidines as kinase inhibitors |
| 01/29/2004 | WO2004009601A1 Azaindole kinase inhibitors |
| 01/29/2004 | WO2004009600A1 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/29/2004 | WO2004009596A2 Pyrazolopyrimidines as kinase inhibitors |
| 01/29/2004 | WO2004009595A1 Combination therapy with 1,3-dioxolanes and inosine monophosphate dehydrogenase inhibitors |
| 01/29/2004 | WO2004009593A1 Preparation of 1h-imidazo[4,5-c]quinolin-4-amines via1h-imidazo [4,5-c]quinolin-4-phthalimide intermediates |
| 01/29/2004 | WO2004009590A1 4-amino-substituted pyrimidine derivatives |
| 01/29/2004 | WO2004009588A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 01/29/2004 | WO2004009586A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 01/29/2004 | WO2004009585A2 Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors |
| 01/29/2004 | WO2004009583A2 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor |
| 01/29/2004 | WO2004009582A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 01/29/2004 | WO2004009579A1 Novel compounds |
| 01/29/2004 | WO2004009578A2 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
| 01/29/2004 | WO2004009575A1 An extract of a typhae pollen and its manufacture and use |
| 01/29/2004 | WO2004009573A1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 01/29/2004 | WO2004009565A2 Acylaminothiazole derivatives, preparation and therapeutic use thereof |
| 01/29/2004 | WO2004009563A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 01/29/2004 | WO2004009562A1 Substituted triazine kinase inhibitors |
| 01/29/2004 | WO2004009560A1 Novel bio-active molecules |
| 01/29/2004 | WO2004009558A2 Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations |
| 01/29/2004 | WO2004009557A1 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 01/29/2004 | WO2004009556A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 01/29/2004 | WO2004009552A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/29/2004 | WO2004009550A1 Piperidine derivatives and their use as selective inhibitors of mip-1alpha binding to its receptor ccr1 |
| 01/29/2004 | WO2004009549A2 Piperidines useful for the treatment of central nervous system disorders |
| 01/29/2004 | WO2004009548A1 1-heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/29/2004 | WO2004009547A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 01/29/2004 | WO2004009546A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 01/29/2004 | WO2004009543A2 1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors |
| 01/29/2004 | WO2004009542A2 Process for preparing certain pyrrolotriazine compounds |
| 01/29/2004 | WO2004009541A2 Antisense modulation of endothelial lipase expression |
| 01/29/2004 | WO2004009538A1 Retinol derivatives, their use in the treatment of cancer and for potentiating the efficacy of other cytotoxic agents |
| 01/29/2004 | WO2004009537A1 NOVEL α-KETOAMIDE DERIVATIVE AND USE THEREOF |
| 01/29/2004 | WO2004009536A1 Novel compounds as histone deacetylase inhibitors |
| 01/29/2004 | WO2004009533A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 01/29/2004 | WO2004009532A1 Polymorphic forms of nateglinide |
| 01/29/2004 | WO2004009531A1 Acetylenic compounds useful in treating inflammatory disorders |
| 01/29/2004 | WO2004009528A1 2,4-dihydroxybenzoic acid derivatives |
| 01/29/2004 | WO2004009527A1 Materials and methods for treating hypercholesterolemia |
| 01/29/2004 | WO2004009521A1 Remedy |
| 01/29/2004 | WO2004009227A2 Biodegradable polyurethane/urea compositions |
| 01/29/2004 | WO2004009147A1 Medical devices comprising a protein-tyrosine kinase inhibitor to inhibit restonosis |
| 01/29/2004 | WO2004009127A1 Localized delivery system for phenstatin using n-isopropylacrylamide |
| 01/29/2004 | WO2004009124A2 Ghrelin-carrier conjugates |
| 01/29/2004 | WO2004009122A1 Mucoadhesive composition and formulation for solubilization of insoluble drugs and preparation method thereof |
| 01/29/2004 | WO2004009121A1 Pharmaceutical compositions comprising hepatitis c viral protease inhibitors |
| 01/29/2004 | WO2004009120A1 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same |
| 01/29/2004 | WO2004009119A1 Medicinal composition for treating arteriosclerosis |
| 01/29/2004 | WO2004009118A1 Preventive for the onset of diabetes |
| 01/29/2004 | WO2004009117A1 Tocolytic agent comprising ep2 agonist as the active ingredient |
| 01/29/2004 | WO2004009113A1 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 01/29/2004 | WO2004009106A1 Preparation extracted from stephania tetrandra s. moor and the use thereof |
| 01/29/2004 | WO2004009100A1 Poly (potassium and sodium styrene sulfonate), its manufacture and its uses |
| 01/29/2004 | WO2004009099A1 Phosphorylated dextran |
| 01/29/2004 | WO2004009097A2 Use of a nad analogue, mono-adp-ribosyl transferase substrate and nad antagonist, for preparing a medicine for treating pathologies related to purinergic receptors |
| 01/29/2004 | WO2004009096A1 Use of compositions comprising salicylic acid and glycyrrhetinic acid for the treatment of acne |
| 01/29/2004 | WO2004009095A1 Use of compositions comprising benzoyl peroxide and glycyrrhetinic acid for the treatment of acne |
| 01/29/2004 | WO2004009094A1 Methods and compositions for treating diabetes mellitis |
| 01/29/2004 | WO2004009093A1 Cholesterol-reducing agent made of dietary fibre and cholesterol-reducing substances |
| 01/29/2004 | WO2004009092A1 Formulations and methods of administration of cephalotaxines, including homoharringtonine |
| 01/29/2004 | WO2004009091A1 Purine derivatives as liver x receptor agonists |
| 01/29/2004 | WO2004009090A1 Therapeutic and screening methods employing partial agonism of the ∝-2a adrenergic receptor subtype |
| 01/29/2004 | WO2004009089A1 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| 01/29/2004 | WO2004009088A1 4-(4-methylpiperazin-1-ylmethyl)-n-[4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating anaplastic thyroid cancer |
| 01/29/2004 | WO2004009087A1 4-4(methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating mutated-ret kinase associated diseases |